Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis March 11, 2019https://www.businesswire.com/news/home/20190311005199/en/Celgene-Submits-Application-EMA-Ozanimod-Treatment-Relapsing-Remitting